TABLE 1.

BASELINE CHARACTERISTICS OF PATIENTS.

Group A (n. 10) Group B (n. 10) Group C (n. 10)
Age (mean ± SEM) 33.9 ± 1.61 27.9 ± 1.55 31.4 ± 0.90
Laparoscopic Diagnosis Endometriosis and Endometriotic Cysts Endometriosis and Endometriotic Cysts Endometriosis and Endometriotic Cysts
Treatment PEA-m® + trans-Polydatin Leuprorelin acetate Ethinylestradiol + Drospirenone
Painful symptom scores to NRS (mean ± SEM)
Chronic pelvic pain 5.3 ± 1.115 4.0 ± 0.76 5.7 ± 1.03
Dyspareunia 5.0 ± 1.07 3.1 ± 1.2 4.3 ± 1.02
Dysmenorrhea 7.5 ± 0.70 5.2 ± 0.94 5.6 ± 0.90
Dyschezia 0.8 ± 0.80 3.3 ± 1.24 1.5 ± 1.07
Dysuria 1.2 ± 0.63 0.7 ± 0.47 0.7 ± 0.52
Quality of Life assessment by SF-12 questionnaire (mean scores ± SEM)
MCS-12
(Mental components)
38.6 ± 3.56 41.3 ± 5.87 47.8 ± 3.18
PCS-12
(Physical components)
43.4 ± 2.24 46.9 ± 2.35 39.5 ± 3.12
Giorn. It. Ost. Gin. Giornale Italiano di Ostetricia e Ginecologia CIC Edizioni Internazionali 2014 March-April; 36(2): 353–358. ISSN: 0391-9013
Published online 2014 May 30.